Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt No Debt
ADAT's Cash to Debt is ranked higher than
85% of the 1620 Companies
in the Global Health Information Services industry.

( Industry Median: 27.13 vs. ADAT: No Debt )
ADAT' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: No Debt

Equity to Asset 0.72
ADAT's Equity to Asset is ranked higher than
77% of the 1591 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. ADAT: 0.72 )
ADAT' s 10-Year Equity to Asset Range
Min: -0.18   Max: 0.94
Current: 0.72

-0.18
0.94
Interest Coverage No Debt
ADAT's Interest Coverage is ranked higher than
86% of the 1074 Companies
in the Global Health Information Services industry.

( Industry Median: 387.00 vs. ADAT: No Debt )
ADAT' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: -18.05
M-Score: -3.45
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -152.70
ADAT's Operating margin (%) is ranked lower than
65% of the 1594 Companies
in the Global Health Information Services industry.

( Industry Median: 5.57 vs. ADAT: -152.70 )
ADAT' s 10-Year Operating margin (%) Range
Min: -562.49   Max: -1.26
Current: -152.7

-562.49
-1.26
Net-margin (%) -235.11
ADAT's Net-margin (%) is ranked lower than
65% of the 1592 Companies
in the Global Health Information Services industry.

( Industry Median: 3.70 vs. ADAT: -235.11 )
ADAT' s 10-Year Net-margin (%) Range
Min: -508.59   Max: -3.95
Current: -235.11

-508.59
-3.95
ROE (%) -130.81
ADAT's ROE (%) is ranked lower than
65% of the 1553 Companies
in the Global Health Information Services industry.

( Industry Median: 6.88 vs. ADAT: -130.81 )
ADAT' s 10-Year ROE (%) Range
Min: -296.91   Max: -17.66
Current: -130.81

-296.91
-17.66
ROA (%) -86.02
ADAT's ROA (%) is ranked lower than
65% of the 1605 Companies
in the Global Health Information Services industry.

( Industry Median: 3.73 vs. ADAT: -86.02 )
ADAT' s 10-Year ROA (%) Range
Min: -115.87   Max: -11.11
Current: -86.02

-115.87
-11.11
ROC (Joel Greenblatt) (%) -284.27
ADAT's ROC (Joel Greenblatt) (%) is ranked lower than
61% of the 1589 Companies
in the Global Health Information Services industry.

( Industry Median: 31.80 vs. ADAT: -284.27 )
ADAT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1806.56   Max: -8.33
Current: -284.27

-1806.56
-8.33
Revenue Growth (%) 9.40
ADAT's Revenue Growth (%) is ranked higher than
76% of the 1208 Companies
in the Global Health Information Services industry.

( Industry Median: 6.40 vs. ADAT: 9.40 )
ADAT' s 10-Year Revenue Growth (%) Range
Min: -53   Max: 16.7
Current: 9.4

-53
16.7
EBITDA Growth (%) -18.20
ADAT's EBITDA Growth (%) is ranked higher than
52% of the 957 Companies
in the Global Health Information Services industry.

( Industry Median: 7.60 vs. ADAT: -18.20 )
ADAT' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 74.7
Current: -18.2

0
74.7
EPS Growth (%) -3.50
ADAT's EPS Growth (%) is ranked higher than
62% of the 899 Companies
in the Global Health Information Services industry.

( Industry Median: 8.80 vs. ADAT: -3.50 )
ADAT' s 10-Year EPS Growth (%) Range
Min: 0   Max: 17.8
Current: -3.5

0
17.8
» ADAT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

ADAT Guru Trades in Q1 2013

Jim Simons 122,400 sh (-3.01%)
» More
Q2 2013

ADAT Guru Trades in Q2 2013

Jim Simons 102,400 sh (-16.34%)
» More
Q3 2013

ADAT Guru Trades in Q3 2013

Jim Simons 85,200 sh (-16.8%)
» More
Q4 2013

ADAT Guru Trades in Q4 2013

Jim Simons 75,700 sh (-11.15%)
» More
» Details

Insider Trades

Latest Guru Trades with ADAT



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 4.70
ADAT's P/B is ranked lower than
62% of the 1504 Companies
in the Global Health Information Services industry.

( Industry Median: 2.45 vs. ADAT: 4.70 )
ADAT' s 10-Year P/B Range
Min: 0.36   Max: 52.5
Current: 4.7

0.36
52.5
P/S 5.30
ADAT's P/S is ranked lower than
76% of the 1650 Companies
in the Global Health Information Services industry.

( Industry Median: 1.98 vs. ADAT: 5.30 )
ADAT' s 10-Year P/S Range
Min: 1.27   Max: 390
Current: 5.3

1.27
390
EV-to-EBIT 0.20
ADAT's EV-to-EBIT is ranked higher than
99% of the 1278 Companies
in the Global Health Information Services industry.

( Industry Median: 17.39 vs. ADAT: 0.20 )
ADAT' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 16.70
ADAT's Price/Net Current Asset Value is ranked lower than
64% of the 672 Companies
in the Global Health Information Services industry.

( Industry Median: 11.00 vs. ADAT: 16.70 )
ADAT' s 10-Year Price/Net Current Asset Value Range
Min: 1.16   Max: 460
Current: 16.7

1.16
460
Price/Tangible Book 6.30
ADAT's Price/Tangible Book is ranked lower than
58% of the 1245 Companies
in the Global Health Information Services industry.

( Industry Median: 4.00 vs. ADAT: 6.30 )
ADAT' s 10-Year Price/Tangible Book Range
Min: 0.64   Max: 130
Current: 6.3

0.64
130
Price/Median PS Value 0.70
ADAT's Price/Median PS Value is ranked higher than
87% of the 1516 Companies
in the Global Health Information Services industry.

( Industry Median: 1.10 vs. ADAT: 0.70 )
ADAT' s 10-Year Price/Median PS Value Range
Min: 0.04   Max: 55.71
Current: 0.7

0.04
55.71
Earnings Yield (Greenblatt) 560.40
ADAT's Earnings Yield (Greenblatt) is ranked higher than
99% of the 1324 Companies
in the Global Health Information Services industry.

( Industry Median: 5.40 vs. ADAT: 560.40 )
ADAT' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1   Max: 922.3
Current: 560.4

1
922.3
Forward Rate of Return (Yacktman) -59.45
ADAT's Forward Rate of Return (Yacktman) is ranked lower than
58% of the 1007 Companies
in the Global Health Information Services industry.

( Industry Median: 5.32 vs. ADAT: -59.45 )
ADAT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -19.9   Max: 229.7
Current: -59.45

-19.9
229.7

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:BID1.Germany
Authentidate Holding Corporation was organized in August 1985 as Bitwise Designs, Inc. and reincorporated under the laws of the state of Delaware in May 1992. The Company changed its name to Authentidate Holding Corp. in March 2001. The Company is a provider of secure web-based software applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. The Company and its subsidiaries provide products and services that address a variety of business needs for its customers, including enabling healthcare organizations to increase revenues, improve productivity, enhance patient care and reduce costs by eliminating paper and manual work steps from clinical, administrative and other processes and enhancing compliance with regulatory requirements. Its web-based services are delivered as Software as a Service (SaaS) to its customers interfacing seamlessly with billing and document management systems. These solutions incorporate multiple features and security technologies such as rules based electronic forms, intelligent routing, transaction management, electronic signatures, identity credentialing, content authentication, automated audit trails and remote patient monitoring capabilities. Both web and fax-based communications are integrated into automated, secure and trusted workflow solutions. Its ExpressMD Solutions joint venture with EncounterCare Solutions, Inc., a provider of technology and services to the home healthcare marketplace, provides in-home patient vital signs monitoring systems and services to improve care for patients with chronic illnesses and reduce the cost of care by delivering results to their healthcare providers via the Internet. ExpressMD Solutions, combines EncounterCare's Electronic House Call patient vital signs monitoring appliances with a web-based management and monitoring software module based on Authentidate's Inscrybe Healthcare platform. The joint venture also offers the ExpressMD Interactive Voice Response (IVR) patient vital signs monitoring solution that provides an alternative for patients who require a flexible, mobile solution for care plan reminders and vital signs monitoring. The Company currently operates its business in the United States with technology and service offerings that address emerging growth opportunities based on the regulatory and legal requirements specific to each market. The business is engaged in the development and sale of web-based services largely based on its Inscrybe platform and related capabilities and telehealth services through its ExpressMD Solutions joint venture. The Company is subject to federal and state laws pertaining to healthcare fraud and abuse, which, among other things, prohibit the offer or acceptance of remuneration intended to induce or in exchange for the purchase of products or services reimbursed under a federal healthcare program and the

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide